That is essential, because the method a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and work. In other words, we have to understand how these proteins fold if we desire a drug to work. Historically, this has been a trial-and-error process (jeff brown stock predictions). Now, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it much easier to create drugs that do what they're developed to do. This was a breakthrough almost no one observed. However it's going to have profound implications for treating disease. I anticipate that Alpha, Fold will be 98% precise by the end of 2021.
And, naturally, there will be a lot of financial investment opportunities in this area, too. Moving topics It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (brownstone research stock). That said, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be amazed if it drew back perhaps substantially prior to going greater - tech predictions. I have actually been covering bitcoin for a long period of time now. One of the first research reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial recommendation, I titled my report "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time. We were mainly informing readers. But that's not the big concern anymore. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche business. Mass, Mutual is a relied on 170-year-old institution. So think of that. In 5 years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a big factor I'm bullish on it this year. last year. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus offer forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than twenty years. These business raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I predict 2021 will be another record year in IPOs. There are numerous fantastic personal companies on the verge of striking the public markets And I have actually been working on a new way for you to invest even prior to these companies go public.
This opportunity has been developing over the last couple of years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to discover all the information. Go right here to schedule your area for complimentary.
Emma Walsh here, handling editor of the Diary. Regular Diary readers understand that tech isn't our typical beat (exponential growth). And when it concerns tech investing, we leave it to the experts. Fortunately, we have a number of such experts in our Rolodex. Our associate Jeff Brown will be familiar to our longtime readers. He is among the most accomplished tech investing professionals we know (tech stock). In fact, he had several triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the huge image and predict what's just around the corner.
That consists of things like 5G networks, biotech, synthetic intelligence, and a lot more. These trends are experiencing exponential growth and creating amazing opportunities for financiers. I wish to make certain all our readers are gotten ready for what's next. And with that in mind, let me draw the image of what I see can be found in the next 12 months Our new 5G (fifth-generation) wireless networks are a topic I have actually been covering for years now. the legacy report prediction. But despite what lots of readers may believe, this is a trend that's simply getting begun. Even though the COVID-19 pandemic disrupted supply chains in 2015, an outstanding 250 million 5G-enabled gadgets were still sold.
And all of this ultimately resulted in Apple delaying the release of the 5G-enabled i, Phone 12 by two months (jeff brown biotech genome sequencing). Losing 2 months of manufacturing and sales really impacts how numerous 5G gadgets are sold in the calendar year. When you consider all of that, selling 250 million units is exceptional. More importantly, the delays brought on by the pandemic created a load of suppressed need. And that need is now going to be pushed into 2021. In truth, I forecast that more than 500 million 5G devices will be shipped in 2021 - biotech stocks. Which's not my only 5G forecast When I've spoken about 5G in the past, I've described its 3 different phases.
In Phase Two, 5G gadgets go on sale. 5G phones and other products start to reach consumers. And in Stage 3, 5G services start to be provided (what is the legacy report predicting). That's when we start to see applications working on 5G networks. Think about things like huge multiplayer games over a mobile phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will start Stage 3 by this summer. This starts something of a virtuous cycle: Many people don't truly appreciate the technology. But they will care if there are amazing applications that can just be accessed with a 5G phone.
That results in more 5G apps being established. In reality, 5G is going to open up a suite of amazing applications: self-driving vehicles, the Web of Things, robotic surgical treatment, and more. All of these technologies require 5G. The investment opportunities going forward will be enormous. Stepping away from 5G, the next essential technology I foresee in 2021 is CRISPR genetic editing. CRISPR means "clustered regularly interspaced brief palindromic repeat." It's a mouthful. But it's one of the most amazing advancements in biotechnology. At a high level, CRISPR is an innovation that can edit our genetic makeup as if it were software application.
The program can crash or not operate correctly. CRISPR utilizes a similar idea however with our genetic code. "Typos" in our genome can lead to disease. CRISPR can remedy these "typos." For many years, CRISPR was mostly a specific niche technology that wasn't well understood. And during that time, there were truly just 3 companies operating in this space. But things are altering. CRISPR is no longer simply theoretical. We're seeing actual results. We're treating diseases and seeing that this technology just works. And as an outcome, a "second crop" of early-stage CRISPR companies is going public and delivering incredible returns. This entire market is efficiently a greenfield opportunity.
There's space for lots of business to exist in this area. jeff brown 1 biotech company. And there will be more. That's my prediction for CRISPR in 2021. I forecast that 2 or 3 more hereditary modifying business will hold their IPOs. Sticking with biotechnology, we are seeing incredible things happening at the merging of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its newest Alpha, Fold software can accurately anticipate the folding of a protein based solely on its amino acid sequence with 92. 4% precision. That is very important due to the fact that the way a protein in the body folds identifies if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has actually been an experimental process. And now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it a lot easier to produce drugs that do what they're designed to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one but numerous drug treatments produced utilizing this technology. This was among those advancements that nearly nobody observed. But it's going to have profound ramifications for curing illness. And, naturally, there will be lots of investment chances in this area, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be surprised if it pulled back maybe substantially before going greater. I've been covering bitcoin for a long time now. Among the first research reports I ever published was on bitcoin - biotech stocks jeff brown. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for any person who followed my suggestion. But at the time of that initial suggestion, I titled my report, "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time.
But no one is asking that question anymore. Now, we're seeing institutional money finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, niche business. jeff brown genome sequencing stock. Mass, Mutual is a 150-year-old institution. So consider that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another bonus prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and claims the details is up to date since February 2021, but we could not separately validate this claim. Given Jeff Brown's past, he likely has a significant net worth, but we can't hammer down an exact figure at this moment. Brown is best understood for his sage-like capability to select winning innovation stocks. He spent more than 25 years looking into technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience provides him an exceptional point of view on the marketplace. He's constantly on the hunt for brand-new opportunities, and he shares a lot of his best picks in the Near Future Report.
That's high appreciation, however it's not ridiculously reasoned. Brown has an excellent credibility as a stock-picker, and he effectively predicted some of the greatest financial occasions of the previous twenty years. Although he doesn't appear to release his picks to the general public, the service's success is a direct indication of Brown's stock-picking prowess. Nobody on Wall Street gets it ideal each time, however Jeff Brown's precise forecasts have actually made him legions of devoted followers. That says a lot about his capability. The Future Report is published by Brownstone Research, a popular monetary research publisher. Brownstone Research offers numerous research services with a wide array of expertises - last week.
The business is also affiliated with Bonner & Partners, another well-respected research study publisher - jeff brown top stock pick 2021. On its website, Brownstone says its objective is to supply retail financiers with professional-grade research: "For too long, the finest financial investment research study has actually not been offered to individual financiers. It has actually been generally scheduled for financial investment banks, hedge funds, personal equity, and high-net-worth clients. the legacy report predictions. The objective of Brownstone Research study is to make that kind of proprietary research offered to any financiers aiming to gain an edge in the marketplaces. The goal is simple to deliver unique and lucrative investment research study found nowhere else." -Brownstone Research study website excerpt from the Jeff Brown is the creator of Brownstone Research study, and he likewise serves as the company's Chief Financial investment Expert.
With Brown directing the ship, Brownstone Research study is a powerhouse publisher with lots to use its customers. After decades of consistent success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a family name throughout many of America. If you know even a little bit about the marketplace, you know that he has a track record as a King Midas of sorts. exponential tech investor. Everything he touches relies on gold! Jeff is well conscious of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge project.
In fact, Brown thinks S.A.V. jeff brown tech stock 2021. could be "the most significant pattern of the 2020s, and he's not alone. Have a look at these quotes from other popular S.A.V. bulls: Elon's next huge act will be weding two innovative innovations: synthetic intelligence and electric cars. Musk hopes the mix will help him establish the first fully-autonomous, self-driving cars and trucks ever. It's absolutely nothing except the vehicle market's Holy Grail. As you know, electric automobiles and self-driving cars and truck stocks have actually been huge this year, however the Wall Street device has approved hype without much tangible result. Regardless of a drastic increase in competition over the previous few years, Brown still thinks Musk has the very best chance of putting it all together.
tech might be the magic string that connects all of it together. S.A.V. means Shared Autonomous Vehicle, and it could be the future of transportation. Generally, this innovation would allow you to lease out your car as a self-governing, self-driving taxi when you're not using it. You just leave the automobile and press a button on an app that informs the vehicle to "join the fleet." Next thing you understand, you're unwinding on your couch while your automobile shuttles ride-sharers around town. Best of all, you get to keep a substantial chunk of the revenues. It sounds insane, however it could be closed than you believe.